Elpro International Ltd — Important, 29-08-2025: Company Update

Elpro International has acquired 60,807 equity shares of Supriya Lifescience Limited for an investment purpose, costing INR 3.95 Crores. This brings Elpro's total holding in Supriya Lifescience to 62,000 equity shares. Supriya Lifescience is a public-listed generic pharmaceutical company specializing in API manufacturing. For its latest financial year, Supriya Lifescience reported a total turnover of INR 706.31 Crores, demonstrating consistent revenue growth over the past three years. This move signifies Elpro's strategic investment in the growing pharmaceutical sector.